What should a buyer do about it — June 30 (Tuesday, H1 Last Day, 6/30 Sailing Day, Positioning Note)?
Today is H1 LAST DAY — June 30, 2026 closes H1 and a note on SUNWARD's positioning goes out today. Tilmicosin Phosphate Q3 window is now day 15 — three working days (Wed 7/1 → Fri 7/3) before early July compression. Florfenicol early July deadline is 3 working days out: Wed 7/1 → Fri 7/3. Colistin Sulfate industry-wide confirmation holds on day 4 — five major producers showing the same supply-side pattern. Tylvalosin 5-6 weeks holds for the thirteenth straight day. Apramycin Sulfate spot stock window day 13. CNY ~6.80 narrow range holds for the thirteenth day. Shipping: TODAY (Tue 6/30) IS H1 LAST DAY AND the 6/30 sailing — orders placed and confirmed today before noon make the last June sailing for late-July/early-August arrival. After today's sailing, the next consolidation is Wednesday 7/1 for mid-August arrival. Positioning note: SUNWARD is a trading company, not a direct factory . Shipping arranged per order, factory to destination port.
Tilmicosin Phosphate: Q3 window day 15 — three working days (7/1-7/3) before early July compression. View Tilmicosin details →
Florfenicol: Early July deadline 3 working days out — lock H2 volume before Friday 7/3. View Florfenicol details →
Colistin Sulfate: Industry-wide confirmation day 4 — five+ major producers aligned on allocation pattern, factory lead times 3-4 weeks. View Colistin details →
Tylvalosin Tartrate: Confirmed at 5-6 weeks for the thirteenth day — order now for early-to-mid August delivery. View Tylvalosin details →
Apramycin Sulfate: Spot stock window day 13 — 1 FCL MOQ trial orders welcome this week. Request Apramycin quote →
Tilmicosin Phosphate — Q3 Window Day 15, H1 Last-Tuesday Decision Day 💡
What happened
Tilmicosin Phosphate Q3 supply window is now day 15 of the open signal flagged June 16. Tuesday H1-last-day reading: the order-confirmation queue is processing the full Monday-Tuesday flow, with the consolidated 6/30 sailing order book visible across AU/NZ, Turkish, and SE Asian buyer profiles. End-of-month budget-release patterns are at peak confirmation velocity — Q3 orders placed today consolidate with the 6/30 sailing. The four remaining flexible H2 capacity slots at three major producers we track are visibly narrower than yesterday; Monday email flow continued through to today's confirmation queue. The Tuesday-morning order book shows the highest single-day confirmation count of the Q3 window. After today's sailing window, the next consolidation is Wednesday 7/1 for mid-August arrival.
SUNWARD's judgment
Day 15 of the Tilmicosin window is the second working day before early July compression, and TODAY's 6/30 sailing is the last June sailing for late-July/early-August arrival. The three working days between tomorrow (Wed 7/1) and Friday (7/3) are the practical decision window — and today (Tue 6/30) is the most concentrated single day for end-of-month budget-release order placements before tomorrow's first July sailing begins. Monday-today buyers who placed orders yesterday still have time for confirmation before noon today for the 6/30 sailing. Buyers who wait until Wednesday (7/1) or later to act have already lost the 6/30 sailing and are sailing in early July for mid-August arrival. After Friday 7/3, the Tilmicosin lead-time floor extends to 4-5 weeks. Ask me for the price and the lead time on this one — I quote per product. Turkey, Indonesia, Pakistan, Bangladesh, and the Philippines. If your H2 Tilmicosin volume is not yet locked, today (Tuesday) is the last cleanest path before early July.
What you can do now
Place your Tilmicosin Phosphate H2 order today or tomorrow — Q3 window day 15, three working days left before early July compression. View product details → or request a quote now. How it ships, and what it costs, is part of the quote: it depends on the product, the quantity and where it is going.
SUNWARD's note: For AU/NZ cattle producers: Tilmicosin BRD formulations for the mid-year production cycle need supply locked before the favorable window closes — today's 6/30 sailing is the last June sailing. For Turkish buyers: end-of-month and end-of-quarter budget releases mean Q3 orders placed by Monday-Tuesday (6/29-6/30) get the best available terms. For Indonesian and Philippine buyers: poultry respiratory formulations peak in July-August, and the lead time difference between orders placed this week vs next week is meaningful. For Pakistani and Bangladeshi buyers: swine and poultry Tilmicosin demand is steady — the favorable terms window is now.
Florfenicol — Early July Deadline 3 Working Days Out, Tuesday Decision Day 🚨
What happened
Florfenicol H2 supply is now 3 working days from the early July deadline confirmed the previous week. Tuesday H1-last-day reading: the order book velocity held through the weekend into Monday-Tuesday at the same steady daily inquiry rate. AU/NZ cattle buyers, Middle East poultry integrators, and SE Asian aquaculture-adjacent applications continue to absorb available capacity. Firm-quote validity windows have stabilized at 3-5 days for several key producers. Factory capacity visible for Q3-Q4 delivery is materially narrower than two weeks ago and shows no sign of re-expansion. The Tuesday inquiry pattern shows the same buyer profile as last week, with end-of-month budget-release patterns from Turkish and South Asian buyers in active placement phase.
SUNWARD's judgment
3 working days is the buffer that separates buyers who will be fine in July from buyers who will not. The buyers who will be fine are the ones who place their Florfenicol H2 orders before Friday 7/3 and accept that the negotiation room is gone. The buyers who will struggle are the ones who treat early July as a soft guideline. The product will still be available in July, but at less favorable terms — longer lead times, firmer pricing, less flexibility on documentation requirements. Ask me for the price and the lead time on this one — I quote per product. Today (Tuesday 6/30) is the practical decision day — this week is the right window. If your H2 Florfenicol volume is not yet locked, the next three working days are the right window.
What you can do now
Lock your Florfenicol H2 supply before Friday 7/3 — early July deadline is 3 working days out, every additional day reduces flexibility. View product details → or request a quote now. How it ships, and what it costs, is part of the quote: it depends on the product, the quantity and where it is going.
SUNWARD's note: For AU/NZ cattle producers: Florfenicol is core API in BRD and swine respiratory formulations — early July deadline applies to your H2 sourcing cycle, decide today or tomorrow. For Turkish buyers: cattle and poultry Florfenicol demand is firming — your order placed by Wednesday 7/1 beats the early July deadline. For Indonesian and Philippine buyers: aquaculture and poultry Florfenicol demand is steady, and the lead time impact of waiting another week is real. For Pakistani and Bangladeshi buyers: swine and poultry Florfenicol volumes are material — lock now, do not extend your decision timeline into July.
Colistin Sulfate — Industry-Wide Confirmation Day 4, Five+ Producers Hold Pattern ⚠️
What happened
Colistin Sulfate industry-wide confirmation holds on day 4. Tuesday H1-last-day reading: the supply-side reshuffle that started as a buyer-side phenomenon in mid-June remains fully reflected in factory scheduling across the entire major-producer panel. Five major producers continue to show the same allocation pattern. Firm-quote validity windows have stabilized at 3-5 days. Order book velocity holds at the same steady daily rate seen across the past week. The fluoroquinolone substitution volumes in SE Asia and South Asia are now a structural part of factory batch planning, not a temporary demand shift. The Tuesday-morning email flows from SE Asian poultry integrators and South Asian swine producers confirm the demand side has fully absorbed the supply-side response.
SUNWARD's judgment
Day 4 of industry-wide confirmation is the floor. Once five major producers show the same allocation pattern for four consecutive days, the pattern is the new normal, not a temporary shift. Buyers who are still evaluating Colistin for H2 swine and poultry formulations have a shorter decision window than they did a week ago. The practical decision window is now: today (Tue 6/30) for 6/30 sailing consolidation, then this week before early July. After early July, Colistin lead times mirror Tylvalosin's 5-6 weeks and Tilmicosin's expected 4-5 week floor. Ask me for the price and the lead time on this one — I quote per product. Turkey, Indonesia, Pakistan, Bangladesh, and the Philippines. The next 1-2 weeks is the practical window — and the practical window is the working-day window, not the calendar-day window.
What you can do now
Evaluate and lock your Colistin Sulfate H2 supply today or tomorrow — industry-wide allocation confirmation (day 4) means the demand shift is durable and the supply-side response is fully aligned. View product details → or request a quote now. How it ships, and what it costs, is part of the quote: it depends on the product, the quantity and where it is going.
SUNWARD's note: For Indonesian and Philippine buyers: Colistin-based swine and poultry reformulation is now fully reflected in supply-side scheduling across five major producers — your window to secure flexible H2 supply is shorter than it was a week ago. For Pakistani and Bangladeshi buyers: poultry and swine Colistin demand is firming on the supply side — act now. For AU/NZ buyers: global Colistin tightening trend affects spot availability — if you have H2 needs, this is the time to lock. For Turkish buyers: swine and poultry Colistin demand is firming across your market with the same industry-wide supply-side response pattern.
Tylvalosin Tartrate — 5-6 Weeks Holds, Thirteenth Day of Confirmed Floor ⏱️
What happened
Tylvalosin Tartrate has now held at 5-6 week lead times for the thirteenth consecutive day. The pattern is fully established: lead times extended, allocations persisting, the negotiation room on pricing and documentation has tightened. Pre-season demand from poultry integrators across SE Asia, the Middle East, and AU/NZ has fully absorbed remaining factory capacity. The 4-5 week window that was available in mid-June is definitively closed. Orders placed today consolidate with the 6/30 sailing for early-to-mid August delivery. Tuesday H1-last-day reading: the floor is stable, no softening signal, no tightening signal — the 5-6 week range is the new normal through mid-July. The Tuesday-morning email flow continues to show poultry-integrator demand from SE Asia and the Middle East, with AU/NZ confirmation patterns extending into mid-week.
SUNWARD's judgment
Tylvalosin buyers: 5-6 weeks is the floor, not the ceiling, and the floor is not going to soften before mid-July. The pattern now matches where Tilmicosin is heading: a stable floor at 4-5 weeks once the seasonal Q3 demand absorbs the remaining flexible capacity. If you need Tylvalosin for Q3 poultry formulations and you haven't ordered yet, the realistic picture is: 5-6 weeks, firm pricing, less documentation flexibility than was available in May. Ask me for the price and the lead time on this one — I quote per product. Today (Tuesday 6/30) is a good time to place Q3 orders so they consolidate with the 6/30 sailing for early-to-mid August delivery. After today's sailing, the next consolidation window is Wednesday 7/1.
What you can do now
Place your Tylvalosin Tartrate Q3 order today or tomorrow — 5-6 weeks confirmed for the thirteenth day, early-to-mid August delivery achievable with 6/30 sailing consolidation. View product details → or request a quote now. How it ships, and what it costs, is part of the quote: it depends on the product, the quantity and where it is going.
Apramycin Sulfate — Spot Stock Window Day 13, Tuesday-Trial Orders Welcome 🎯
What happened
Apramycin Sulfate spot stock is active as the working week continues, with factory production available for immediate dispatch on small-lot trial orders. Apramycin is widely used in swine and poultry formulations for gastrointestinal and respiratory applications, and the spot-stock window is a practical option for buyers who are not yet ready to commit to larger H2 volume but want to keep a working supply line open. MOQ 1 FCL applies, same as our standard veterinary API terms. Tuesday H1-last-day reading (day 13 of the spot-stock window): the spot stock has held through Monday into the working week, but the 1-2 week window is now in its second week — once trial orders are filled, lead times revert to standard 3-4 week production. Tuesday-morning trial-order inquiry patterns from SE Asian poultry integrators and South Asian swine producers continue.
SUNWARD's judgment
Apramycin spot stock is the safety valve for buyers in a "wait and see" posture, and the safety valve is closing. If you are evaluating Apramycin for swine E. coli or poultry formulations and want to trial at 1 FCL before committing to larger H2 volume, this week is the right time to do it. The spot-stock window is finite — the 1-2 week window is the real signal, not a soft guideline. After that, lead times revert to standard 3-4 week production and the trial order convenience is gone. Ask me for the price and the lead time on this one — I quote per product. Place your trial order this week — Tuesday or Wednesday preferred — to take advantage of the spot window before it closes mid-week.
What you can do now
Request an Apramycin Sulfate trial quote at 1 FCL MOQ today or tomorrow — spot stock window day 13. Request a quote now. How it ships, and what it costs, is part of the quote: it depends on the product, the quantity and where it is going.
FX Watch: CNY ~6.80 Narrow Range, Thirteenth Day — Stable Anchor Continues, Lock H2 Contracts Now 💱
What happened
USD/CNY continues to hold in a narrow range, with the mid-rate at approximately 6.7990 on 6/26 (latest onshore fix) and expected to hold in the 6.78-6.81 band into early July. The pair has now spent thirteen consecutive trading days within a 0.5% band of the mid-June 6.77 anchor. The slight appreciation from 6/25 6.8157 to 6/26 6.7990 is supported by ongoing PBOC fixing patterns and stable trade flow dynamics. AUD/CNY is around 4.78, EUR/CNY is around 7.28, TRY/CNY is around 0.20. Tuesday 6/30 is a trading day in China — the H1-final onshore fix is expected mid-morning Beijing time and will be the last H1 reference point.
SUNWARD's judgment
The 6.80 range is now well within the predictability zone — within 0.4% of the 6.77 mid-June anchor that we have been tracking for thirteen trading days. This stability is the most predictable variable in the entire supply picture. Use it. Lock your H2 CNY contracts now while the rate is stable — SUNWARD provides firm CNY quotes valid for 7 days, so your Q3 and Q4 pricing doesn't get caught by unexpected FX movement. The combination of stable CNY + tightening product lead times is exactly the environment where buyers benefit from locking both sides early. End-of-month is a natural budget cycle, and CNY 6.80 is your starting point for any Q3 or Q4 conversations today. Tuesday's onshore fix is the H1-final reference point — closes H1 cleanly.
What you can do now
Lock your H2 CNY contracts now at ~6.80. Specify quantity, destination port, and delivery window in any quote request — SUNWARD provides firm quotes within two business days. Get your quote now.
Shipping: Tuesday H1 Last-Tuesday Window — TODAY TUESDAY 6/30 IS H1 LAST DAY AND THE 6/30 SAILING 🚢
What happened
Shipping rates move with the season and the port. Tuesday H1-last-day reading: today is Tuesday 6/30 — H1 last day AND the last June sailing. Today is the day the consolidated Monday-Tuesday order book gets loaded for the 6/30 vessel departure. Orders placed and confirmed today BEFORE NOON consolidate with the 6/30 sailing for late-July/early-August arrival. Orders placed this afternoon or Wednesday 7/1 morning or later will sail in early July for mid-August arrival. Global rate declines affecting Europe and US routes have not meaningfully relieved rates on China-to-Asia-Pacific and China-to-Middle East lanes. China to Turkey (Istanbul/Izmir): 25-35 days, 20GP approximately $1,200-$1,600. China to AU/NZ: 18-25 days, rates firming. China to SE Asian ports (Jakarta, Karachi, Chittagong, Manila): 12-20 days, 20GP from $850-$1,200, LCL consolidation available for orders under 500kg.
SUNWARD's judgment
TODAY (Tue 6/30) IS H1 LAST DAY AND the 6/30 sailing — the last June sailing for late-July/early-August arrival. The combination of tightening product lead times (Tilmicosin day 15 of favorable phase, Florfenicol 3 working days out, Tylvalosin 5-6 weeks) and tightening shipping capacity makes this Tuesday decision critical. Get your product order locked today before noon, then confirm sailing schedule. SUNWA If your H2 product needs to land at destination port in late July or early August, the 6/30 sailing is the last June sailing available. Use the Tuesday handoff. After today's sailing, the next consolidation window opens Wednesday 7/1 for mid-August arrival. H1 closes cleanly today.
What you can do now
Place your order today (Tue 6/30) before noon to make the 6/30 sailing — the last June sailing for late-July/early-August arrival. Include your preferred delivery window and destination port in any quote request. How it ships, and what it costs, is part of the quote: it depends on the product, the quantity and where it is going.
Positioning Note — SUNWARD Positioning: Trading Company vs. Direct Factory 🏛️
What the positioning note says
Today, June 30, 2026 — H1 last day — the site publishes a note on SUNWARD's positioning: we are a trading company, not a direct factory. It comes from a question a multinational buyer keeps asking: whether SUNWARD owns its GMP plants. The answer is: no, we don't. SUNWARD runs multi-factory sourcing — we audit, qualify, and consolidate qualified Chinese factories for buyers who don't have a China presence or who want a single point of contact for documentation, MOQ flexibility, and logistics. Where the product is a veterinary drug, the plant has to be GMP-certified for the material to be exportable at all, so on the veterinary lines that certification is a regulatory requirement rather than a qualification anyone adds.
SUNWARD's judgment
The trading-company role is exactly what small-to-medium veterinary API importers need: one contact, one documentation package, one consolidated shipment. The MNCs (multinational corporations) who asked the factory-ownership question are typically working with their own qualified supplier lists and don't need SUNWARD's consolidation role — for them, SUNWARD isn't the right channel. The buyers who benefit most are the ones who have not yet locked their China supply line, who want MOQ flexibility (1 FCL), who need full GMP documentation per batch, and who are placing 1-5 MT per quarter across multiple SKUs. SUNWARD's value is in the consolidated service: documentation, MOQ flexibility, freight coordination — not factory ownership. This note clarifies the boundary for both sides: SUNWARD is for buyers who want a trading partner, not for buyers who want a factory-direct relationship.
What you can do now
Read the positioning note for the full context on SUNWARD's positioning and the boundary between trading-company sourcing and factory-direct purchasing. Browse the SUNWARD blog hub → or discuss your China sourcing needs directly.
SUNWARD's note: For Tier-1 multinational buyers: SUNWARD's position is honest — we don't have a competitive advantage for direct-factory pricing against your existing qualified supplier lists. For small-to-medium veterinary API importers: SUNWARD's trading-company consolidation model is precisely the service layer that makes sense when you are buying 1 FCL trial orders up to multi-MT annual volumes across multiple products and need documentation, MOQ flexibility, and consolidated shipping from one point of contact. The two audiences are different. SUNWARD is committed to the second audience. FAQ anchor for the week: "Does SUNWARD work with large multinationals?" — Yes, but only for buyers whose SKU mix and volume profile doesn't conflict with their existing qualified supplier lists.
Which products are worth watching this week?
Veterinary APIs (Core Focus)
Surfactants & Personal Care
Inorganic Chemicals
Organic Chemicals
Food Additives
What is the bottom line for buyers?
- Tilmicosin: 💡 Q3 window day 15 — H1 last-Tuesday decision day, three working days (7/1-7/3) before early July compression
- Florfenicol: 🚨 Early July deadline 3 working days out — order book velocity steady, lock H2 volume before Friday 7/3
- Colistin: ⚠️ Industry-wide confirmation day 4 — five major producers aligned on allocation pattern, factory lead times 3-4 weeks
- Tylvalosin: ⏱️ Confirmed at 5-6 weeks (thirteenth day) — 4-5 week window closed, early-to-mid August delivery
- Apramycin: 🎯 Spot stock window day 13 — 1 FCL MOQ trial orders welcome this week
- CNY: ~6.80 in narrow range (thirteenth day) — slight appreciation, well within 0.5% of mid-June 6.77 anchor, lock H2 contracts now
- Shipping: TODAY (Tue 6/30) IS H1 LAST DAY AND the 6/30 sailing — last June sailing for late-July/early-August arrival, orders before noon still make it
- Positioning note: SUNWARD is a trading company, not a direct factory. The note publishes today.
Sourcing multiple products? SUNWARD can consolidate your veterinary API order — Tilmicosin, Florfenicol, Colistin, Tylvalosin, Apramycin, and others — arrange combined shipping, and manage documentation (GMP files, COA) under one shipment. Small orders from one FCL welcome. How it ships, and what it costs, is part of the quote: it depends on the product, the quantity and where it is going.
This Week's Procurement Tips
Place your order today (Tue 6/30) before noon to make the 6/30 sailing — the last June sailing for late-July/early-August arrival. After today's sailing, July consolidations begin, with the first window on Wed 7/1. Request consolidated shipping quote →
Lock your H2 Florfenicol volume before Friday 7/3. Today (Tue) or Wednesday (7/1) is the practical decision window. View Florfenicol →
Q3 window day 15. After Friday 7/3, lead times extend to 4-5 weeks and pricing loses negotiation room. Tilmicosin Phosphate →
SUNWARD is a trading company, not a direct factory . Trading-company consolidation model — documentation, MOQ flexibility, consolidated freight — for small-to-medium importers buying 1 FCL up to multi-MT. Read the positioning note →
H1 Closing Note — Today (Tue 6/30) Closes H1, SUNWARD Positioning: Trading Company vs. Direct Factory, July Sailing Consolidation Begins Wednesday 7/1
Today (Tuesday 6/30) closes H1 — the last working day of June, the last June sailing. The positioning note goes out today: SUNWARD is a trading company, not a direct factory. For buyers, the practical implication of today's H1 close is straightforward: any Q3 orders placed and confirmed today (before noon for the 6/30 sailing, or anytime during the day for the Wednesday 7/1 sailing consolidation) lock in early-to-mid August arrival. The Friday 7/3 deadline for Florfenicol early-July-compression remains firm. After today, July consolidations begin — and the first July sailing window opens Wednesday 7/1.